Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07593443

Application for Arts-Based Social Prescribing

The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.

The main question it aims to answer is:

Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.

Participants will:

Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.

Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).

If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

15 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants must meet the following criteria:

  • Aged 15-18 years enrolled in Medicaid managed care
  • Positive screen for depression and/or anxiety (e.g., PHQ-2 or GAD-2 ≥ 3)
  • Currently own and easily operate a smartphone
  • Have a valid e-mail address checked regularly
  • English fluency, and
  • Have a stable treatment regimen for at least 30 days prior to baseline with no planned treatment changes.

Exclusion criteria

Participants will be excluded if they:

  • Endorse current suicidal ideation at study screening, defined as a response ≥ 1 ("several days") on Item 9 of the PHQ-9A
  • Initiate a new treatment regimen or plan on initiating a new treatment regimen (i.e., medication, psychotherapy, or mind-body interventions) at the time of enrollment.

Treatment and study plan

Art Pharmacy

Behavioral

A personalized arts-based social prescribing program

Stable treatment

Other

Stable treatment (no change to existing care) through Medicaid managed care

Primary outcomes

  1. Anxiety - Generalized Anxiety Disorder-7 (GAD-7)

    Time frame: At baseline, and 3-, 6-, 9- and 12-month follow up.

    The GAD-7 is a 7-item self-report measure of anxiety symptoms. Scores range from 0 to 21, with higher scores indicating greater anxiety severity.

  2. Depression - Patient Health Questionnaire-9 Adolescent Version (PHQ-9A)

    Time frame: At baseline, and 3-, 6-, 9- and 12-month follow up.

    The PHQ-9A is a 9-item self-report measure of depressive symptoms in adolescents. Scores range from 0 to 27, with higher scores indicating greater depression severity.

  3. Loneliness - UCLA Loneliness Scale

    Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up

    The UCLA Loneliness Scale assesses subjective feelings of loneliness and social isolation. Scores range from 20 - 80, with higher scores indicating a higher degree of loneliness.

  4. Social Connectedness - Social Connectedness Scale-Revised (SCS-R)

    Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up

    The SCS-R measures feelings of interpersonal closeness and connectedness. Scores range from 20 to 120, with higher scores indicating greater social connectedness.

Secondary outcomes

  1. Treatment Utilization - Treatment and Arts/Cultural Engagement Utilization Questionnaire

    Time frame: At baseline, and 3-, 6-, 9-, and 12-month follow up

    A study-developed questionnaire assessing participant engagement with behavioral health treatment and arts/cultural activities. Higher scores/frequencies indicate greater utilization and engagement.

Study contacts

Contact information is provided by the study sponsor or research team.

Peter Research & Evaluation Manager

CONTACT

[email protected]

845-807-8005

Sponsors and collaborators

Lead sponsor

SocialRx Inc

Industry

Collaborators

  • Boston College
  • National Center for Complementary and Integrative Health (NCCIH)

Registry information

Official study title

Member Engagement Application for Personalized Arts-based Social Prescriptions

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
May 18, 2026
Registry last updated
May 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.